Use of the engrailed homeodomain protein as anxiolytic
US8575105B2 · kind B2 · utility
2Cited by
2References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 28, 2007 |
| Grant date | Nov 5, 2013 |
| Priority date | — |
| Expiry date | Apr 1, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of an Engrailed transcription factor for producing a medicament for anxiolytic purposes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.